The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement
Abstract
The American Society of Clinical Oncology (ASCO) convened a subcommittee to develop recommendations on improving the evidence base for treating older adults with cancer in response to a critical need identified by the Institute of Medicine. Older adults experience the majority of cancer diagnoses and deaths and make up the majority of cancer survivors. Older adults are also the fastest growing segment of the US population. However, the evidence base for treating this population is sparse, because older adults are underrepresented in clinical trials, and trials designed specifically for older adults are rare. The result is that clinicians have less evidence on how to treat older adults, who represent the majority of patients with cancer. Clinicians and patients are forced to extrapolate from trials conducted in younger, healthier populations when developing treatment plans. This has created a dearth of knowledge regarding the risk of toxicity in the average older patient and about key end points of importance to older adults. ASCO makes five recommendations to improve evidence generation in this population: (1) Use clinical trials to improve the evidence base for treating older adults with cancer, (2) leverage research designs and infrastructure for generating evidence on older adults with cancer, (3) increase US Food and Drug Administration authority to incentivize and require research involving older adults with cancer, (4) increase clinicians' recruitment of older adults with cancer to clinical trials, and (5) use journal policies to improve researchers' reporting on the age distribution and health risk profiles of research participants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
Hutchins, L. F., Unger, J. M., Crowley, J. J., Coltman, C. A., & Albain, K. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412706 · Cited by 2,174
Participation in Cancer Clinical Trials: Race-, Sex-, and Age-Based Disparities
Murthy, V. H., Krumholz, H. M., & Gross, C. P. (2004) · JAMA · doi:10.1001/jama.291.22.2720 · Cited by 2,078
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study
Hurria, A., Togawa, K., Mohile, S. G., Owusu, C., Klepin, H. D., Gross, C. P., Lichtman, S. M., Gajra, A., Bhatia, S., Katheria, V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.7625 · Cited by 1,841 · cited 1×
“benefit or not from treatment, because factors other than age are crucial to making these assessments.(46-53) Clinical trials conducted by”
Self-citationUnderstanding the Treatment Preferences of Seriously Ill Patients
Fried, T. R., Bradley, E. H., Towle, V. R., & Allore, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa012528 · Cited by 1,522
Age and acute myeloid leukemia
Appelbaum, F. R., Gundacker, H., Head, D. R., Slovak, M. L., Willman, C. L., Godwin, J. E., Anderson, J. E., & Petersdorf, S. H. (2006) · Blood · doi:10.1182/blood-2005-09-3724 · Cited by 1,350
Extermann, M., Boler, I., Reich, R. R., Lyman, G. H., Brown, R. H., DeFelice, J., Levine, R. M., Lubiner, E. T., Reyes, P., Schreiber, F. J., et al. (2012) · Cancer · doi:10.1002/cncr.26646 · Cited by 1,143
Van Spall, H. G. C., Toren, A., Kiss, A., & Fowler, R. A. (2007) · JAMA · doi:10.1001/jama.297.11.1233 · Cited by 1,055
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis
Levit, L. A., Balogh, E. P., Nass, S. J., & Ganz, P. A. (2014) · Cited by 1,040
Self-citationParticipation of Patients 65 Years of Age or Older in Cancer Clinical Trials
Lewis, J. H., Kilgore, M. L., Goldman, D. P., Trimble, E. L., Kaplan, R., Montello, M. J., Housman, M. G., & Escarce, J. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.010 · Cited by 1,031
Juliusson, G., Antunovic, P., Derolf, Å., Lehmann, S., Möllgård, L., Stockelberg, D., Tidefelt, U., Wahlin, A., & Höglund, M. (2009) · Blood · doi:10.1182/blood-2008-07-172007 · Cited by 987
A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients
Sargent, D. J., Goldberg, R. M., Jacobson, S. D., Macdonald, J. S., Labianca, R., Haller, D. G., Shepherd, L. E., Seitz, J. F., & Francini, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010957 · Cited by 986
Finding What Works in Health Care: Standards for Systematic Reviews
Eden, J., Levit, L. A., Berg, A. O., & Morton, S. C. (2013) · Cited by 943
Self-citationDose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
Bonadonna, G., & Valagussa, P. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040103 · Cited by 774
Talarico, L., Chen, G., & Pazdur, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.175 · Cited by 727
Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer
Diab, S. G. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.550 · Cited by 674
Systematic Review of Barriers to the Recruitment of Older Patients With Cancer Onto Clinical Trials
Townsley, C. A., Selby, R., & Siu, L. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.141 · Cited by 583
Leith, C. P., Kopecky, K. J., Chen, I. M., Eijdems, L., Slovak, M. L., McConnell, T. S., Head, D. R., Weick, J. K., Grever, M. R., Appelbaum, F. R., et al. (1999) · PubMed · doi:10.1182/blood.v94.3.1086.415k32_1086_1099 · Cited by 573
Age and Adjuvant Chemotherapy Use After Surgery for Stage III Colon Cancer
Schrag, D., Cramer, L. D., Bach, P. B., & Begg, C. B. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.850 · Cited by 481
Barriers to Clinical Trial Participation by Older Women With Breast Cancer
Kemeny, M. M., Peterson, B. L., Kornblith, A. B., Muss, H. B., Wheeler, J., Levine, E., Bartlett, N., Fleming, G., & Cohen, H. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.124 · Cited by 465
Self-citationUnder-Representation of Older Adults in Cancer Registration Trials: Known Problem, Little Progress
Scher, K. S., & Hurria, A. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.6727 · Cited by 432
Self-citationPublic Attitudes Toward Participation in Cancer Clinical Trials
Comis, R. L., Miller, J. D., Aldigé, C. R., Krebs, L., & Stoval, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.105 · Cited by 393
Rapid-Learning System for Cancer Care
Abernethy, A. P., Etheredge, L. M., Ganz, P. A., Wallace, P., German, R. R., Neti, C., Bach, P. B., & Murphy, S. B. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.5478 · Cited by 365
Hurria, A., Dale, W., Mooney, M., Rowland, J. H., Ballman, K. V., Cohen, H. J., Muss, H. B., Schilsky, R. L., Ferrell, B., Extermann, M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0418 · Cited by 362
Self-citationImplementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401
Hurria, A., Cirrincione, C. T., Muss, H. B., Kornblith, A. B., Barry, W., Artz, A. S., Schmieder, L., Ansari, R., Tew, W. P., Weckstein, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.6985 · Cited by 350
Self-citationRepresentation of older patients in cancer treatment trials
Trimble, E. L., Cain, D., Ungerleider, R. S., Friedman, M. A., Carter, C. L., & Freidlin, B. (1994) · Cancer · doi:10.1002/1097-0142(19941001)74:7+<2208::aid-cncr2820741737>3.0.co;2-# · Cited by 343
Wildiers, H., Mauer, M., Pallis, A., Hurria, A., Mohile, S. G., Luciani, A., Curigliano, G., Extermann, M., Lichtman, S. M., Ballman, K., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.6125 · Cited by 322
Self-citationScoggins, J. F., & Ramsey, S. D. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq291 · Cited by 318
Deaths: leading causes for 2010.
Heron, M. P. (2013) · PubMed · Cited by 317
Lyman, G. H., Dale, D. C., Friedberg, J., Crawford, J., & Fisher, R. I. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.213 · Cited by 315
Fröhling, S., Schlenk, R. F., Kayser, S., Morhardt, M., Benner, A., Döhner, K., Döhner, H., & for the German-Austrian AML Study Group (2006) · Blood · doi:10.1182/blood-2006-04-014324 · Cited by 300
Stewart, J. H., Bertoni, A. G., Staten, J. L., Levine, E. A., & Gross, C. P. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9500-y · Cited by 263
Ellis, P. M. (2000) · Annals of Oncology · doi:10.1023/a:1008342222205 · Cited by 260
Knowing What Works in Health Care: A Roadmap for the Nation
Eden, J., Wheatley, B., McNeil, B., & Sox, H. C. (2008) · University Libraries (University of Maryland) · doi:10.13016/zoku-ylou · Cited by 246
Oncologists' reluctance to accrue patients onto clinical trials: an Illinois Cancer Center study.
Benson, A. B., Pregler, J. P., Bean, J. A., Rademaker, A. W., Eshler, B., & Anderson, K. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.11.2067 · Cited by 241
Aparicio, T., Jouve, J.-L., Teillet, L., Gargot, D., Subtil, F., Le Brun-Ly, V., Cretin, J., Locher, C., Bouché, O., Breysacher, G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.9894 · Cited by 216
Can older cancer patients tolerate chemotherapy?: A prospective pilot study
Chen, H., Cantor, A., Meyer, J., Beth Corcoran, M., Grendys, E., Cavanaugh, D., Antonek, S., Camarata, A., Haley, W., Balducci, L., et al. (2003) · Cancer · doi:10.1002/cncr.11110 · Cited by 203
Kornblith, A. B., Kemeny, M., Peterson, B. L., Wheeler, J., Crawford, J., Bartlett, N., Fleming, G., Graziano, S., Muss, H., Cohen, H. J., et al. (2002) · Cancer · doi:10.1002/cncr.10792 · Cited by 180
Self-citationInitial National Priorities for Comparative Effectiveness Research
(2009) · National Academies Press eBooks · doi:10.17226/12648 · Cited by 174
Giovanazzi-Bannon, S., Rademaker, A., Lai, G., & Benson, A. B. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.11.2447 · Cited by 172
Simon, M. S., Du, W., Flaherty, L., Philip, P. A., Lorusso, P., Miree, C., Smith, D., & Brown, D. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.005 · Cited by 163
Gupta, S. K., & Lamont, E. B. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52461.x · Cited by 153
Siminoff, L. A., Zhang, A., Colabianchi, N., Sturm, C. M. S., & Shen, Q. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.6.1203 · Cited by 149
Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older Adults
Klepin, H. D., Rao, A. V., & Pardee, T. S. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.1564 · Cited by 146
Drug Policy for an Aging Population — The European Medicines Agency's Geriatric Medicines Strategy
Cerreta, F., Eichler, H., & Rasi, G. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1209034 · Cited by 138
Reducing patient eligibility criteria in cancer clinical trials.
George, S. L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.4.1364 · Cited by 131
Wildes, T. M., Ruwe, A. P., Fournier, C., Gao, F., Carson, K. R., Piccirillo, J. F., Tan, B. R., & Colditz, G. A. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.02.002 · Cited by 131
Dhruva, S. S. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.56 · Cited by 128
Improving the Quality of Cancer Care in an Aging Population: Recommendations From an IOM Report
Hurria, A., Naylor, M., & Cohen, H. J. (2013) · JAMA · doi:10.1001/jama.2013.280416 · Cited by 127
Self-citationBiological, Clinical, and Psychosocial Correlates at the Interface of Cancer and Aging Research
Dale, W., Mohile, S. G., Eldadah, B. A., Trimble, E. L., Schilsky, R. L., Cohen, H. J., Muss, H. B., Schmader, K. E., FERRELL, B. R., Extermann, M., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs145 · Cited by 122
Self-citationHurria, A., Wong, F. L., Villaluna, D., Bhatia, R., Chung, C. T., Mortimer, J. E., Hurvitz, S. A., & Naeim, A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.6891 · Cited by 119
Self-citationModernizing Eligibility Criteria for Molecularly Driven Trials
Kim, E. S., Bernstein, D. S., Hilsenbeck, S. G., Chung, C. H., Dicker, A. P., Ersek, J. L., Stein, S., Khuri, F. R., Burgess, E. F., Hunt, K. K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.1854 · Cited by 115
Self-citationJavid, S. H., Unger, J. M., Gralow, J. R., Moinpour, C. M., Wozniak, A. J., Goodwin, J. W., Lara, P. N., Williams-Piehota, P. A., Hutchins, L. F., Gotay, C. C., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0384 · Cited by 108
Impact of the Year 2000 Medicare Policy Change on Older Patient Enrollment to Cancer Clinical Trials
Unger, J. M., Coltman, C. A., Crowley, J. J., Hutchins, L. F., Martino, S., Livingston, R. B., Macdonald, J. S., Blanke, C. D., Gandara, D. R., Crawford, E. D., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.8928 · Cited by 105
Barriers to clinical trials: Part III: Knowledge and attitudes of health care providers
Mansour, E. G. (1994) · Cancer · doi:10.1002/1097-0142(19941101)74:9+<2672::aid-cncr2820741815>3.0.co;2-x · Cited by 103
Ramjaun, A., Nassif, M. O., Krotneva, S., Huang, A. R., & Meguerditchian, A. N. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.04.002 · Cited by 96
Field, M. J., & Boat, T. F. (2013) · Cited by 85
Mandelblatt, J. S., Sheppard, V. B., Hurria, A., Kimmick, G. G., Isaacs, C. J., Taylor, K. L., Kornblith, A. B., Noone, A., Luta, G., Tallarico, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.3295 · Cited by 84
Self-citationThe Roles Of Patents And Research And Development Incentives In Biopharmaceutical Innovation
Grabowski, H. G., DiMasi, J. A., & Long, G. (2015) · Health Affairs · doi:10.1377/hlthaff.2014.1047 · Cited by 80
Patterns of Chemotherapy Use for Women With Ovarian Cancer: A Population-Based Study
Cress, R. D., O’Malley, C. D., Leiserowitz, G. S., & Campleman, S. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.065 · Cited by 78
The influence of older age on breast cancer treatment decisions and outcome
Merchant, T. E., McCormick, B. L., Yahalom, J., & Borgen, P. I. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)02167-1 · Cited by 73
Geriatric oncology research in the cooperative groups: A report of a SIOG special meeting
Hurria, A., Cohen, H. J., & Extermann, M. (2010) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2010.03.005 · Cited by 69
Self-citationKesselheim, A. S. (2011) · Milbank Quarterly · doi:10.1111/j.1468-0009.2011.00636.x · Cited by 62
Melisko, M., Hassin, F., Metzroth, L., Moore, D., Brown, B. A., Patel, K., Rugo, H. S., & Tripathy, D. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.008 · Cited by 55
Variability in the Treatment of Elderly Patients with Stage IIIA (N2) Non–Small-Cell Lung Cancer
Berry, M. F., Worni, M., Pietrobon, R. S., D’Amico, T. A., & Akushevich, I. V. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828916aa · Cited by 41
Bellera, C. A., Praud, D., Petit-Monéger, A., McKelvie‐Sebileau, P., Soubeyran, P., & Mathoulin‐Pélissier, S. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.01.007 · Cited by 41
Muss, H. B. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003461 · Cited by 41
Self-citationSpiraling Costs Threaten Gridlock
Malakoff, D. (2008) · Science · doi:10.1126/science.322.5899.210 · Cited by 33
Assessment of Geriatric Information on the Drug Label for Commonly Prescribed Drugs in Older People
Steinmetz, K. L., Coley, K. C., & Pollock, B. G. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53273.x · Cited by 32
Do we protect or discriminate? Representation of senior adults in clinical trials
Kaźmierska, J. (2012) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2012.08.006 · Cited by 24
Cited by
Mohile, S. G., Dale, W., Somerfield, M. R., Schonberg, M. A., Boyd, C. M., Burhenn, P. S., Canin, B., Cohen, H. J., Holmes, H. M., Hopkins, J. O., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8687 · Cited by 1,479
Self-citationBluethmann, S. M., Mariotto, A. B., & Rowland, J. H. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0133 · Cited by 1,146
“, especially those aged 85 years and older) compared with other older adults, and how this burden may change over time (8).”
BackgroundLi, D., Sun, C.-L., Kim, H., Soto-Perez-de-Celis, E., Chung, V., Koczywas, M., Fakih, M., Chao, J., Cabrera Chien, L., Charles, K., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.4158 · Cited by 481
Self-citationSedrak, M. S., Freedman, R. A., Cohen, H. J., Muss, H. B., Jatoi, A., Klepin, H. D., Wildes, T. M., Le‐Rademacher, J. G., Kimmick, G. G., Tew, W. P., et al. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21638 · Cited by 471
Self-citationSoto-Perez-de-Celis, E., Li, D., Yuan, Y., Lau, Y. M., & Hurria, A. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30348-6 · Cited by 400
Self-citation
Metadata
- Authors
- Hurria, A., Levit, L. A., Dale, W., Mohile, S. G., Muss, H. B., Fehrenbacher, L., Magnuson, A., Lichtman, S. M., Bruinooge, S. S., Soto-Perez-de-Celis, E., Tew, W. P., Postow, M. A., & Cohen, H. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-11-10
- Volume
- 33
- Issue
- 32
- Pages
- 3826-3833
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2149386818
- Cited by
- 419
- References
- 69
- FWCI
- 16.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.